Merck & Co Inc (MRK)
106.73
-0.58
(-0.54%)
USD |
NYSE |
Sep 21, 16:00
106.98
+0.25
(+0.23%)
Pre-Market: 20:00
Merck Enterprise Value: 301.41B for Sept. 21, 2023
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 21, 2023 | 301.41B |
| September 20, 2023 | 302.88B |
| September 19, 2023 | 303.01B |
| September 18, 2023 | 304.18B |
| September 15, 2023 | 303.42B |
| September 14, 2023 | 305.24B |
| September 13, 2023 | 304.15B |
| September 12, 2023 | 307.22B |
| September 11, 2023 | 306.16B |
| September 08, 2023 | 307.30B |
| September 07, 2023 | 304.48B |
| September 06, 2023 | 300.80B |
| September 05, 2023 | 303.39B |
| September 01, 2023 | 309.30B |
| August 31, 2023 | 307.12B |
| August 30, 2023 | 310.24B |
| August 29, 2023 | 309.68B |
| August 28, 2023 | 306.99B |
| August 25, 2023 | 310.24B |
| August 24, 2023 | 308.31B |
| August 23, 2023 | 313.01B |
| August 22, 2023 | 302.68B |
| August 21, 2023 | 308.80B |
| August 18, 2023 | 307.68B |
| August 17, 2023 | 306.97B |
| Date | Value |
|---|---|
| August 16, 2023 | 306.49B |
| August 15, 2023 | 306.31B |
| August 14, 2023 | 306.94B |
| August 11, 2023 | 303.21B |
| August 10, 2023 | 298.47B |
| August 09, 2023 | 299.81B |
| August 08, 2023 | 300.60B |
| August 07, 2023 | 299.79B |
| August 04, 2023 | 297.02B |
| August 03, 2023 | 298.87B |
| August 02, 2023 | 298.80B |
| August 01, 2023 | 297.73B |
| July 31, 2023 | 301.21B |
| July 28, 2023 | 300.62B |
| July 27, 2023 | 297.91B |
| July 26, 2023 | 302.66B |
| July 25, 2023 | 303.65B |
| July 24, 2023 | 306.85B |
| July 21, 2023 | 310.91B |
| July 20, 2023 | 306.01B |
| July 19, 2023 | 299.63B |
| July 18, 2023 | 299.63B |
| July 17, 2023 | 298.67B |
| July 14, 2023 | 303.16B |
| July 13, 2023 | 300.57B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
176.33B
Minimum
Mar 23 2020
323.61B
Maximum
Jun 30 2023
233.78B
Average
221.18B
Median
Dec 31 2020
Enterprise Value Benchmarks
| Amgen Inc | 171.40B |
| Johnson & Johnson | 407.64B |
| Eli Lilly and Co | 538.31B |
| Pfizer Inc | 206.30B |
| Moderna Inc | 29.69B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.975B |
| Revenue (Quarterly) | 15.04B |
| Total Expenses (Quarterly) | 20.05B |
| EPS Diluted (Quarterly) | -2.35 |
| Gross Profit Margin (Quarterly) | 73.24% |
| Profit Margin (Quarterly) | -39.74% |
| Earnings Yield | 1.14% |
| Operating Earnings Yield | 2.35% |
| Normalized Earnings Yield | 1.364 |